Transforming Monocyte Based Cell Therapy Manufacturing Via Elutriation

Monocyte derived immunotherapies are providing a promising new outlook on treating a variety of human cancers and diseases, but there are challenges to monocyte isolation during manufacturing. In order to address the inefficiencies caused by the existing manual and semi-manual methods, Invetech has developed the Korus platform - a fully automated, closed counterflow centrifuge system that can enrich monocyte populations from a full leukopak in less than an hour.

Consider this data when choosing a platform to meet your isolation needs. It demonstrates the efficient and effective enrichment and concentration of a monocyte cell population, starting with a healthy donor leukopak using the Korus Platform.